Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
MEDIROM Healthcare Technologies ( (MRM) ) has provided an update.
On January 21, 2025, MEDIROM Healthcare Technologies announced the completion of its corporate capital registration procedures following an offering of 2,860,000 common shares. This offering, which closed on December 11, 2024, marked the first follow-on registered underwritten public offering by a Japanese company listed solely on a U.S. stock exchange. The proceeds of approximately $5 million will be used for working capital, investments, acquisitions, and strategic collaborations. The completion of this offering strengthens MEDIROM’s position in the healthcare industry, as it aims to improve profitability and growth while expanding its customer base both in Japan and internationally.
More about MEDIROM Healthcare Technologies
MEDIROM Healthcare Technologies Inc., headquartered in Tokyo, Japan, operates in the health technology and holistic healthcare industry. The company manages over 300 wellness salons across Japan, with its leading brand being Re.Ra.Ku®. In 2015, MEDIROM expanded into the health tech business by launching an on-demand training app called ‘Lav®’. In 2020, it ventured into the device business with the development of the ‘MOTHER Bracelet®’ smart tracker. More recently, in 2023, the company launched REMONY, a remote monitoring system aimed at corporate clients from various industries.
YTD Price Performance: -1.98%
Average Trading Volume: 195,325
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $7.82M
See more insights into MRM stock on TipRanks’ Stock Analysis page.
